Suresh Nayak, MD
Orthopaedic Surgery · Cincinnati, OHNPI 1730184946
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $426,723 of the $536,266 with a category attached, or 79.6%. Stryker accounts for 89.6% of it on its own, with 11 other manufacturers making up the rest. Among orthopaedic surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 347 payments — averaging $1545.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$481K
- Heron Therapeutics, Inc.$43K
- Vertex$12K
- Orthalign Inc$289
- Ferring Pharmaceuticals Inc.$138
- Pacira Therapeutics, Inc.$119
- plus $167 from 6 others
Across 6 payments — averaging $3333.27 each. An ownership or investment interest held by the physician or an immediate family member.
- Orthalign Inc$20K
What the payments were for
- Consulting fees$426,72380%
- Speaking & faculty fees$26,1505%
- Travel & lodging$77,45014%
- Food & beverage$5,9431%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 262 | $480,563 |
| Heron Therapeutics, Inc. | 47 | $43,333 |
| Vertex | 14 | $11,657 |
| Orthalign Inc | 3 | $289 |
| Ferring Pharmaceuticals Inc. | 7 | $138 |
| Pacira Therapeutics, Inc. | 6 | $119 |
| Johnson & Johnson | 1 | $43 |
| Pfizer | 2 | $42 |
| Medtronic | 1 | $28 |
| Smith+Nephew | 2 | $26 |
| Orthofix Medical, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$536,266 in reported general payments places this provider in the 95th percentile of 794 orthopaedic surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 355 | $1,001 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 281 | $886 |
| Methylprednisolone | 67 | $403 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 34 | $349 |
| Diclofenac Sodium | 24 | $327 |
| Clindamycin Hcl | 77 | $297 |
| Mupirocin | 47 | $286 |
| Celecoxib | 12 | $138 |
| Cephalexin | 21 | $117 |
| Tizanidine Hcl | 30 | $109 |
| Ondansetron Hcl | 19 | $86 |
| Prednisone | 17 | $39 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Cincinnati
- Michael ArchdeaconCincinnati$2.3M
- Paul FavoritoCincinnati$961K
- Michael SwankCincinnati$563K
- Jonathon SpanyerCincinnati$193K
- John WyrickCincinnati$169K
- Robert RolfCincinnati$128K
- Todd KelleyCincinnati$71K
- Reuben GobezieCleveland$12M
- Gregory BerletWorthington$9.6M
- Wael BarsoumCleveland$8.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.